CTOs on the Move


 
  • Number of Employees:
  • Annual Revenue:

  • ,

Executives

Name Title Contact Details

Similar Companies

Federal Reserve Board

The Federal Reserve Board, commonly known as the Fed, is the central authority of the Federal Reserve System, which serves as the central banking system of the United States. Established in 1913, the Fed aims to create a stable monetary system and address banking panics. Headquartered in Washington, D.C., it oversees 12 regional Federal Reserve Banks, balancing regional insights with national policy. The Fed has five main functions: conducting monetary policy to promote maximum employment and stable prices, ensuring financial system stability, supervising and regulating financial institutions, fostering efficient payment and settlement systems, and promoting consumer protection and community development. It also provides essential services such as payment processing and economic data publications, including the Beige Book and the FRED database. The Fed plays a crucial role in supporting the U.S. economy and serves various stakeholders, including depository institutions, the U.S. government, and foreign official institutions.

Assured Legacy

Assured Legacy is a health and life insurance agency that is partnered with multiple Insurance Companies to help clients find plans and policies that best fit their needs. Our Licensed Insurance Benefits Advisors guide clients through the process of assessing and understanding which benefit plans best align with their future needs and financial goals. Please visit assuredlegacy.net to learn more and schedule a no-obligation - complimentary consultation with a Licensed Insurance Benefits Advisor.

Harvey Performance Company

Harvey Performance Company, established in 1985 and based in Rowley, Massachusetts, is a prominent designer and manufacturer of specialty carbide cutting tools for precision machining. The company operates under five brands: Harvey Tool, Helical Solutions, Micro 100, Titan USA, and CoreHog, with additional facilities in Gorham, Maine; Meridian, Idaho; and West Springfield, Massachusetts. With a workforce of around 350 employees, it is led by President and CEO Peter Jenkins. The company specializes in high-performance cutting tools, including micro-tools, end mills, and custom tooling solutions, tailored for industries such as aerospace, medical devices, electronics, telecommunications, and general machining. Harvey Performance is known for its fast service, comprehensive product support, and technical expertise, catering to manufacturers that require extreme precision and tight tolerances. The company also actively participates in community initiatives and workforce development, supporting local technical schools and charitable events.

IMUNON

IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.